Cells protect themselves better than expected - new discovery reveals surprising defence strategy

A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of certainty years before the onset of symptoms. As a result, in the future, diagnostic and therapeutic measures could be taken early enough to delay or even prevent the onset of the disease. The corresponding research has just been published in the journal Nature Communications.

A research team at the Medical University of Vienna has systematically described the safety and efficacy of targeted immunotherapy in refractory idiopathic inflammatory myopathies (IIM) for the first time. The results of the retrospective observational study were published in the journal Rheumatology.

A research team led by Gregor Weihs has developed a method for the deliberate control of dark excitons in quantum dots.

A research team at the Medical University of Vienna led by Dietmar Herndler-Brandstetter has investigated how bone marrow niches orchestrate immune cell development and promote long-term survival and function of mature immune cells. The study reveals that stromal cell subtypes have a different capacity to produce the survival cytokine interleukin 15 (IL-15) and thereby differently regulate the development and survival of immune cells. The results have been published in the Journal "Nature Communications".